Visualization of Epidermal Reservoir Formation from Topical Diclofenac Gels by Raman Spectroscopy.
Raman microscopy
diclofenac
drug permeation
epidermal reservoir
skin depot
topical pain relief
Journal
Journal of pain research
ISSN: 1178-7090
Titre abrégé: J Pain Res
Pays: New Zealand
ID NLM: 101540514
Informations de publication
Date de publication:
2020
2020
Historique:
received:
13
04
2020
accepted:
09
06
2020
entrez:
6
8
2020
pubmed:
6
8
2020
medline:
6
8
2020
Statut:
epublish
Résumé
This work investigated whether topical pain relief diclofenac gels can form a diclofenac reservoir in the epidermal and dermal layers of human skin. Excised human skin samples were treated with three topical diclofenac gels ex vivo and examined using Raman microscopy of transversally microtomed sections. The relative diclofenac concentration in the skin layers was calculated as the ratio of the integrated areas of bands characteristic of diclofenac (~445 cm A heterogenous spatial distribution of diclofenac was clearly visible in both the epidermis and the dermis in all samples, with a markedly higher diclofenac relative content and number of pixels above the detection limit in the epidermis compared to the dermis. The Raman images evidenced that the studied topical gels deliver diclofenac through the stratum corneum skin barrier and form a drug depot localized in the epidermis. The data are in line with earlier clinical findings that this depot acts like a true reservoir and enables sustained drug release.
Identifiants
pubmed: 32753939
doi: 10.2147/JPR.S253069
pii: 253069
pmc: PMC7342390
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1621-1627Informations de copyright
© 2020 Zhang et al.
Déclaration de conflit d'intérêts
Mila Boncheva Bettex is an employee of GSK Consumer Healthcare S.A. Skin samples were contracted to Charles River Laboratories in studies directed by Leanne Page and Susan Whitson. The spectroscopic work was contracted to Rutgers University and performed by Qihong Zhang, Carol R. Flach, and Richard Mendelsohn. This work was funded by GSK Consumer Healthcare S.A. The authors report no other conflicts of interest in this work.
Références
J Pain Res. 2012;5:401-8
pubmed: 23166444
Drug Des Devel Ther. 2015 Feb 13;9:835-40
pubmed: 25709408
J Pain Res. 2010 Nov 10;3:223-33
pubmed: 21197326
Int J Pharm. 2014 Oct 1;473(1-2):607-16
pubmed: 25091375
Adv Drug Deliv Rev. 2013 Feb;65(2):152-68
pubmed: 22525516
Eur J Pharm Sci. 2018 May 7;121:59-64
pubmed: 29746912
J Clin Pharmacol. 2010 Jan;50(1):50-61
pubmed: 19841157
Skin Pharmacol Physiol. 2004 Jan-Feb;17(1):3-16
pubmed: 14755122
Pharm Res. 1999 Sep;16(9):1392-8
pubmed: 10496655
Br J Clin Pharmacol. 2012 Apr;73(4):564-78
pubmed: 21999217
Curr Med Res Opin. 2017 Sep;33(9):1623-1634
pubmed: 28681621
Int J Pharm. 2017 Aug 30;529(1-2):55-64
pubmed: 28636892
Biopharm Drug Dispos. 1994 Aug;15(6):441-9
pubmed: 7993982